Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

allergy

This page shows the latest allergy news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more

Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more

Teva lifted by approval for EpiPen generic. The FDA has approved Teva’s version of Mylan’s EpiPen, making it the first generic competitor to costly emergency allergy treatment. ... This approval means patients living with severe allergies who require

Latest news

More from news
Approximately 13 fully matching, plus 193 partially matching documents found.

Latest Intelligence

  • Asthma: beyond the blue and the brown Asthma: beyond the blue and the brown

    for prevention of cat and ragweed allergies.

  • Deal Watch July 2016 Deal Watch July 2016

    And Finally, Reality Bites. ALK-Abello has issued a press release announcing that Merck &Co has walked away from the deal agreed in 2007 (with Schering-Plough) for the allergy treatments ... Grastek and Ragwitek are sublingual allergy immunotherapy (SLIT)

  • Allergies and asthma Allergies and asthma

    Allergies and asthma. Reframing the conversation from disease burden to prevention and health promotion. ... The safest way to manage allergy symptoms is to tackle them before they set in.

  • Coming to an understanding Coming to an understanding

    We derived greater insight and intelligence.”. A similar process on the composition of an allergy panel for product testing had the physicians working in groups to devise their 'panel of the

  • Deal Watch February 2016 Deal Watch February 2016

    Annapurna brings a portfolio of four AAV-based gene therapy programmes at the preclinical stage for alpha-1 antitrypsin deficiency, hereditary angioedema, cardiomyopathy associated with Friedreich's ataxia and severe allergy.

More from intelligence
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest appointments

  • ALK-Abello appoints Søren Jelert as CFO ALK-Abello appoints Søren Jelert as CFO

    Dansih allergy immunotherapy company ALK-Abello has appointed Søren Jelert as its new chief financial officer, a role that sees him succeed Flemming Pederson at the pharmaceutical company. ... to become a truly global allergy company.”.

  • Cytovation expands management team Cytovation expands management team

    Grego is currently chief executive officer of Spire Bioventures, a global healthcare consultancy and mentoring service, and has previously held a number of management positions at Spanish allergy specialist Laboratorios LETI.

  • Lars Dreiøe joins Sobi in senior quality and compliance role Lars Dreiøe joins Sobi in senior quality and compliance role

    He will join the firm in January from Danish allergy vaccine company ALK Abelló, where he was international head of quality.

  • ARC names chairman and member of the board ARC names chairman and member of the board

    ARC is a privately held biopharma company developing desensitisation treatments for food allergies. ... Iwicki said: “ ARC is working to address a very compelling therapeutic area and provide an option to those dealing with food allergies.

  • Insmed appoints FDA's Dr Eugene Sullivan Insmed appoints FDA's Dr Eugene Sullivan

    He also spent a seven-year spell from 1999 at the FDA, where he held several positions, including deputy director of its Pulmonary and Allergy Products division.

More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest from PMHub

  • Hanson Zandi

    Allergy Therapeutics - Allergy products. CSL Behring - Corporate, Critical care, Immunology.

  • Allergies – Always a story

    It also ties in nicely with  Allergy Awareness Week, which runs from 20-26th April, run by Allergy UK. ... The number of stories around allergy will undoubtedly increase with this awareness raising week.

  • Double Communiqué award win for 90TEN

    90TEN and IPG created the Wheals of Despair programme, which took the real-life stories of people living with CSU alongside insights from Allergy UK and health professionals to create a

  • Artificial Intelligence: the new healthcare algorithm

    Crucially, this can result in improved patient outcomes and even the possibility of using an individual patient’ s history - such as previous illnesses, allergies or even  genetic makeup - to predict their

  • What does programmatic advertising mean for your pharma marketing strategy?

    These adverts have been used in the key disease areas of cancer, allergies, dermatology, smoking cessation, and dental care, with pharmaceutical companies, hospital systems, medical devices, clinical trial and insurance companies

More from PMHub
Approximately 2 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Quick links

Infographics

Multimedia